強力なV-ATPase阻害剤サリチリハラミドAおよび関連する化合物の総合合成と初期構造機能分析
Yusheng Wu1, Xibin Liao, Ruifang Wang
1Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9038, USA.
Journal of the American Chemical Society
|March 28, 2002
まとめ
サリチリハラミドAは天然産物で,真空 (H+) -ATPaseの強力な阻害剤である. 全体の合成と構造機能の研究は,骨粗鬆症と癌の治療のための可能性を明らかにしています.
科学分野:
- 自然製品 化学 化学
- オーガニック・シンセシス オーガニック・シンセシス
- バイオケミストリー バイオケミストリー
背景:
- サリチリハラミドAは,マクロサイクルサリチラート天然製品です.
- 独特の細胞毒性を発揮し,哺乳類の真空 (H+) -ATPASEを阻害する.
- そのメカニズムを理解し,その類似性を開発することは極めて重要です.
研究 の 目的:
- サリチリハラミドAの両方のエナントオメアの全合成を達成するために.
- 自然製品の絶対的な構成を修正する.
- 合成アナログを用いた構造・機能研究を行う.
主な方法:
- 効率的な合成戦略は,E選択的環閉オレフィンメタテシスを含む.
- ステレオ制御によるE-アルケニルイソシアネート中間物質の精製.
- イソシアネートに核性添加により,サリチルヒカリアミドAおよび同類物質が得られます.
主要な成果:
- サリチリハラミドAエナンチオメアの両方の完全な合成が成功しました.
- サリチリハラミドAが,精製されたV-ATPaseの強力な阻害剤であることを実証した.
- ダイマーを含む強力なサイドチェーン改変誘導体の特定.
結論:
- 合成戦略により,サリチリハラミドAの包括的な研究が可能です.
- サリチリハラミドAは強力なV-ATPase阻害剤です.
- アナログは,骨粗鬆症と癌の治療薬の開発に有望を示しています.
さらに関連する動画
関連する概念動画
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:18ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
01:30ATP Driven Pumps III: V-type Pumps
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...